Work

MGMT Promoter Methylation is an Independent Prognostic Factor in the Absence of Alkylating Chemotherapy in Glioblastoma

Year: 2008

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2008.06.787

Authors: C.E. Pelloski, A.L. Rivera, C. De La Cruz Guerrero, K.D. Aldape

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2047229573

FWCI: 0.293

Cites:

Cited by: 5

Related to: 10